Mirtazapine for Charles Bonnet syndrome [7]

Canadian Journal of Psychiatry

Volumn 49, Issue 11, 2004, Pages 787-788

  Siddiqui, Zakaria ^a   Ramaswmay, Sriram ^a   Petty, Frederick ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ERYTHROPOIETIN; MIRTAZAPINE; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ADULT; CASE REPORT; CHARLES BONNET SYNDROME; DRUG EFFICACY; DRUG TOLERANCE; FOLLOW UP; HUMAN; LETTER; MALE; MINI MENTAL STATE EXAMINATION; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; VISUAL HALLUCINATION;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; HALLUCINATIONS; HUMANS; MALE; MIANSERIN; MIDDLE AGED; SYNDROME;

EID: 11844272678     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (11)

1. Manford M, Andermann F. Complex visual hallucinations. Clinical and neurobiological insights. Brain 1998;121:1819-40.
2. Saiz Gonzales D, Diaz Marsa M. The Charles Bonnet syndrome: a case report and a brief review. Actas Esp Psiquiatr 2003;31(1):48-52.
3. Maeda K, Shirayama Y, Nukina S, Yoshioka S, Kawahara R. Charles Bonnet syndrome with visual hallucinations of childhood experience: successful treatment of 1 patient with risperidone. J Clin Psychiatry 2003;64:1131-2.
4. Bathia MS, Khastgir U, Malik SC. Charles Bonnet syndrome. Br J Psychiatry 1992;161:409-10.
5. Batra A, Bariels M, Wormstall H. Therapeutic options in Charles Bonnet syndrome. Acta Psychiatr Scand 1997;96:129-33.
6. Hori H, Terao T, Shiraishi Y, Nakamura J. Treatment of Charles Bonnet syndrome with valproate. Int Clin Psychopharmacol 2000;15:117-9.
7. Ranen NG, Pasternak RE, Rovner BW. Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome. Am J Geriatr Psychiatry 1999;7:264-6.
8. Zoldan J, Friedberg G, Livneh M, Melamed E. Psychosis in advanced Parkinsons' disease: treatment with ondansetron, a 5HT3 receptor antagonist. Neurology 1995;45:1305-8.
9. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
10. Fawcett J, Barkin RL. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression. J Affect Disord 1998;51:267-85.
11. Steinberg H, Saravay SM, Wadhwa N, Pollack S, Maesaka J. Erythropoietin and visual hallucinations in patients on dialysis. Psychosomatics 1996;37:556-63.